IN2012DN00359A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00359A IN2012DN00359A IN359DEN2012A IN2012DN00359A IN 2012DN00359 A IN2012DN00359 A IN 2012DN00359A IN 359DEN2012 A IN359DEN2012 A IN 359DEN2012A IN 2012DN00359 A IN2012DN00359 A IN 2012DN00359A
- Authority
- IN
- India
- Prior art keywords
- agent
- omeprazole
- antioxidant
- directed
- oral administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22689009P | 2009-07-20 | 2009-07-20 | |
PCT/US2010/042508 WO2011011351A2 (en) | 2009-07-20 | 2010-07-20 | A stable pharmaceutical omeprazole formulation for oral administration |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN00359A true IN2012DN00359A (cs) | 2015-05-22 |
Family
ID=43465734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN359DEN2012 IN2012DN00359A (cs) | 2009-07-20 | 2010-07-20 |
Country Status (11)
Country | Link |
---|---|
US (1) | US8530500B2 (cs) |
EP (1) | EP2456439A4 (cs) |
JP (1) | JP2012533633A (cs) |
AU (1) | AU2010276404A1 (cs) |
CA (1) | CA2768024A1 (cs) |
CL (1) | CL2012000169A1 (cs) |
CO (1) | CO6491061A2 (cs) |
EC (1) | ECSP12011618A (cs) |
IN (1) | IN2012DN00359A (cs) |
PE (1) | PE20120781A1 (cs) |
WO (1) | WO2011011351A2 (cs) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140328861A1 (en) * | 2011-12-16 | 2014-11-06 | Atopix Therapeutics Limited | Combination of CRTH2 Antagonist and a Proton Pump Inhibitor for the Treatment of Eosinophilic Esophagitis |
GB201306720D0 (en) | 2013-04-12 | 2013-05-29 | Special Products Ltd | Formulation |
WO2017145146A1 (en) | 2016-02-25 | 2017-08-31 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
GB2561355A (en) * | 2017-04-10 | 2018-10-17 | Eaststone Ltd | Pharmaceutical composition and a method for manufacturing the same |
CN107397719A (zh) * | 2017-08-16 | 2017-11-28 | 洛阳市兽药厂 | 一种畜禽用奥美拉唑可溶性粉剂及其制备工艺 |
GB2585628A (en) * | 2019-05-08 | 2021-01-20 | Alkaloid Ad | Pharmaceutical formulation |
GB2616663A (en) * | 2022-03-18 | 2023-09-20 | Alkaloid Ad Skopje | Pharmaceutical formulation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US20050054682A1 (en) * | 1996-01-04 | 2005-03-10 | Phillips Jeffrey O. | Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same |
RS50023B (sr) | 1999-02-23 | 2008-09-29 | Merck & Co. Inc., | Farmaceutski sastav koji sadrži inhibitore protonske pumpe |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
AR045068A1 (es) | 2003-07-23 | 2005-10-12 | Univ Missouri | Formulacion de liberacion inmediata de composiciones farmaceuticas |
MXPA06011820A (es) | 2004-04-16 | 2006-12-15 | Santarus Inc | Combinacion de inhibidor de bomba de proton, agente regulador del ph y agente procinetico. |
US20090123390A1 (en) * | 2007-11-13 | 2009-05-14 | Meritage Pharma, Inc. | Compositions for the treatment of gastrointestinal inflammation |
-
2010
- 2010-07-20 WO PCT/US2010/042508 patent/WO2011011351A2/en active Application Filing
- 2010-07-20 IN IN359DEN2012 patent/IN2012DN00359A/en unknown
- 2010-07-20 CA CA2768024A patent/CA2768024A1/en not_active Abandoned
- 2010-07-20 EP EP10802745A patent/EP2456439A4/en not_active Withdrawn
- 2010-07-20 PE PE2012000062A patent/PE20120781A1/es not_active Application Discontinuation
- 2010-07-20 US US12/839,495 patent/US8530500B2/en not_active Expired - Fee Related
- 2010-07-20 AU AU2010276404A patent/AU2010276404A1/en not_active Abandoned
- 2010-07-20 JP JP2012521716A patent/JP2012533633A/ja not_active Abandoned
-
2012
- 2012-01-19 CO CO12007902A patent/CO6491061A2/es not_active Application Discontinuation
- 2012-01-20 EC ECSP12011618 patent/ECSP12011618A/es unknown
- 2012-01-20 CL CL2012000169A patent/CL2012000169A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2011011351A3 (en) | 2011-05-19 |
US20110015233A1 (en) | 2011-01-20 |
CO6491061A2 (es) | 2012-07-31 |
EP2456439A4 (en) | 2012-12-26 |
EP2456439A2 (en) | 2012-05-30 |
AU2010276404A1 (en) | 2012-02-02 |
PE20120781A1 (es) | 2012-06-27 |
US8530500B2 (en) | 2013-09-10 |
JP2012533633A (ja) | 2012-12-27 |
WO2011011351A2 (en) | 2011-01-27 |
ECSP12011618A (es) | 2012-04-30 |
CL2012000169A1 (es) | 2012-08-31 |
CA2768024A1 (en) | 2011-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN00359A (cs) | ||
WO2009121039A3 (en) | Administration of benzodiazepine compositions | |
WO2008085765A3 (en) | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | |
WO2009115178A3 (de) | Gingival-wafer | |
MX351584B (es) | Formulacion farmaceutica acuosa de tapentadol para administracion oral. | |
MX336741B (es) | Composiciones farmaceuticas de moduladores de c-met. | |
EA201290984A1 (ru) | Гелеобразные фармацевтические композиции, препятствующие злоупотреблению | |
MX2009011165A (es) | Formulaciones farmaceuticas que contienen derivados del acido lipoico. | |
ZA200800239B (en) | Mucosal or enteral administration of biobogically active macromolecules | |
HK1158969A1 (en) | Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration | |
TN2012000392A1 (en) | Oral formulations and lipophilic salts of methylnaltrexone | |
WO2012174158A3 (en) | Administration of benzodiazepine | |
WO2012009723A8 (en) | C-met modulator pharmaceutical compositions | |
EP2258350A3 (en) | Taste masked dosage form containing roflumilast | |
WO2011086093A3 (en) | Pharmaceutical compositions for oral administration of insulin peptides | |
WO2009149056A3 (en) | Combinations of niacin and an oxicam | |
WO2010009140A3 (en) | Methods, systems and devices for administration of chlorine dioxide | |
WO2008046865A3 (en) | Long-term feed - elderly | |
WO2014137797A3 (en) | Stable glucokinase activator compositions | |
EP2263637A4 (en) | MEDICINAL PREPARATION FOR ORAL ADMINISTRATION | |
EA201200485A1 (ru) | Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол | |
WO2011076840A3 (en) | Aerosol formulation for copd | |
WO2010079433A3 (en) | Pharmaceutical composition comprising melogliptin | |
WO2009048940A3 (en) | Diacerein pharmaceutical formulations | |
WO2010029093A3 (en) | Compositions for percutaneous administration |